Mette Cathrine Oerngreen: Clinical Trials

1 trial sponsored by Mette Cathrine Oerngreen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Mette Cathrine Oerngreen: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Paracetamol Study in Patients With Low Muscle Mass
Paracetamol 120Mg/5mL Oral Suspension - SMA II, Cerebral Palsy
Phase 4UnknownMette Cathrine Oerngreen482019-02-182024-02-22

Conditions studied

Cerebral Palsy (1)  ·  Spinal Muscular Atrophies of Childhood (1)

Interventions

Acetaminophen (1)  ·  Suspensions (1)

Countries

Denmark (1)

NIH funding

2018 (1)